TrialPharmacopsychiatry2022

Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study.

Kirsten R Müller-Vahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.